Ivan P. Gergel is VP at NEKTAR THERAPEUTICS (NKTR). They have made 1 open-market trade across 1 company since 2017, most recently 2017-10-02.
CIK 0001328288
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| NKTR | 41,575 | $1.5M |
Shares reported on the most recent Form 4, priced at the 2017-10-03 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| NKTR | SELL | 2017-09-29 | 2017-10-03 | $24.14 | $2.4M | -5.3% | -4.0% | +135.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.